par Early Breast Cancer Trialists' Collaborative Group (EBCTCG), S;Darby, P;McGale, C;Correa, C;Taylor, R.;Arriagada, M.J.;Clarke, D;Cutter, C;Davies, M;Ewertz, J;Godwin, Richard;Gray, Kimberly;Pierce, Timothy J;Whelan, Yiwei;Wang, R ;Peto,
Référence Lancet, 378, 9804, page (1707-1716)
Publication Publié, 2011-11
Référence Lancet, 378, 9804, page (1707-1716)
Publication Publié, 2011-11
Article révisé par les pairs
Titre: |
|
Auteur: | Early Breast Cancer Trialists' Collaborative Group (EBCTCG), S; Darby, P; McGale, C; Correa, C; Taylor, R.; Arriagada, M.J.; Clarke, D; Cutter, C; Davies, M; Ewertz, J; Godwin, Richard; Gray, Kimberly; Pierce, Timothy J; Whelan, Yiwei; Wang, R; Peto, |
Informations sur la publication: | Lancet, 378, 9804, page (1707-1716) |
Statut de publication: | Publié, 2011-11 |
Sujet CREF: | Cancérologie |
MeSH keywords: | Age Factors |
Breast Neoplasms -- mortality -- therapy | |
Estrogen Antagonists -- therapeutic use | |
Female | |
Humans | |
Lymphatic Metastasis | |
Mastectomy, Segmental | |
Neoplasm Grading | |
Neoplasm Recurrence, Local -- epidemiology | |
Radiotherapy, Adjuvant | |
Randomized Controlled Trials as Topic | |
Receptors, Estrogen -- metabolism | |
Tamoxifen -- therapeutic use | |
Note générale: | Journal Article |
Meta-Analysis | |
Research Support, Non-U.S. Gov't | |
Review | |
Langue: | Anglais |
Identificateurs: | urn:issn:0140-6736 |
info:doi/10.1016/S0140-6736(11)61629-2 | |
info:pii/S0140-6736(11)61629-2 | |
info:pmid/22019144 | |
PMC3254252 |